
Novalis LifeSciences
North America, Virginia, United States, Hampton
Description
Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.
Investor Profile
Novalis LifeSciences has made 20 investments, with 0 in the past 12 months and 65% as lead.
Stage Focus
- Series B (40%)
- Series D (15%)
- Series C (15%)
- Post Ipo Equity (10%)
- Series Unknown (10%)
- Series A (5%)
- Seed (5%)
Country Focus
- United States (80%)
- Belgium (10%)
- The Netherlands (5%)
- United Kingdom (5%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Analytics
- Life Science
- Medical Device
- Agriculture
- Health Diagnostics
- Agtech
- Chemical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.